Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Evaluation of Arts-Based Storytelling Program in Adolescents With Diabetes

7 de agosto de 2026 atualizado por: University of California, San Francisco

The goal of this clinical trial is to evaluate whether an arts-based storytelling and narrative medicine workshop series can improve social connection, illness identity, and psychological well-being in adolescents and young adults with chronic illness, specifically diabetes.

The main questions it aims to answer are:

  • Does participation in a narrative-based storytelling workshop improve social connectedness and peer support among adolescents and young adults with diabetes?
  • Does engagement in creative arts and reflective storytelling support identity formation, self-expression, and emotional well-being in this population?

Participants will be 16-25 years old and recruited through the UCSF Pediatric Diabetes Clinic. Individuals must be able to participate in group workshops and complete surveys and interviews related to the study.

Participants will:

  • Attend eight weekly workshops centered on storytelling, reflection, and creative expression
  • Engage in narrative medicine activities, including writing, storytelling, drawing, and facilitated reflection
  • Participate in group discussions focused on personal experiences with chronic illness
  • Complete pre- and post-intervention surveys assessing psychosocial outcomes such as social connectedness, illness identity, self-concept, and mental well-being
  • Participate in interviews and reflective exercises about their experiences in the program

This study aims to explore the role of narrative medicine and arts-based interventions in supporting adolescents and young adults with chronic illness and assess their potential benefits as a supplement to standard medical care.

Visão geral do estudo

Status

Ativo, não recrutando

Condições

Intervenção / Tratamento

Tipo de estudo

Intervencional

Inscrição (Estimado)

10

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

  • Estados Unidos
    • California
      • San Francisco, California, Estados Unidos, 94107
        • University of California, San Francisco

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Filho
  • Adulto

Aceita Voluntários Saudáveis

Não

Descrição

Inclusion Criteria:

  • Participants must be patients at the UCSF Pediatric Diabetes Clinic
  • Participants must have a self-reported diagnosis of diabetes
  • Participants must be between 16-25 years old
  • The participant and/or caregiver(s) must be English-speaking

Exclusion Criteria:

  • Participants unable to attend the first session

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Cuidados de suporte
  • Alocação: N / D
  • Modelo Intervencional: Atribuição de grupo único
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Arts-Based Storytelling Workshop Series
Participants in this study will take part in an eight-week arts-based storytelling workshop series designed to promote social connection, self-expression, illness identity development, and psychological well-being in adolescents and young adults with diabetes. Workshops will be conducted weekly and will include: -Close engagement with written, visual, or artistic materials centered on themes such as identity, resilience, relationships, uncertainty, growth, and coping with chronic disease - Facilitated group discussions and sharing intended to foster peer support, connection, emotional processing, and self-expression - Creative arts exercises, including writing, storytelling, drawing, or other forms of creative expression in response to structured prompts
Comportamental: Arts-Based Storytelling Workshop Series
The Arts-Based Storytelling Workshop Series is a structured eight-week behavioral intervention designed to enhance self-expression, social connection, emotional reflection, and psychological well-being in adolescents and young adults with diabetes. This intervention differs from traditional educational or counseling approaches by integrating creative expression, guided reflection, and group dialogue as therapeutic tools. Each weekly session includes: -Engagement with written, visual, or artistic prompts centered on themes such as identity, resilience, relationships, coping, uncertainty, and growth in the context of chronic illness -Facilitated group discussion and sharing designed to promote peer support, emotional processing, and a sense of community among participants - Creative exercises in response to structured prompts, including writing, storytelling, drawing, or other expressive activities that support personal reflection

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Participant retention and attendance
Prazo: Throughout intervention (Weeks 1-8), assessed immediately post-intervention (Week 8)
Feasibility will be assessed by tracking the number of participants who attend each of the 8 weekly sessions, including overall completion of the program.
Throughout intervention (Weeks 1-8), assessed immediately post-intervention (Week 8)
Participant satisfaction
Prazo: Immediately post-intervention (Week 8)
Acceptability will be assessed using post-intervention satisfaction questionnaires with 5-point Likert-scale items and semi-structured individual interviews. Measures will evaluate perceived relevance of workshop content, usefulness of creative prompts, quality of group discussion, and facilitation experience. Scale title: Intervention Satisfaction Questionnaire (ISQ) Minimum value: 1 (Strongly Disagree) Maximum value: 5 (Strongly Agree) Interpretation: Higher scores indicate greater satisfaction with the intervention.
Immediately post-intervention (Week 8)

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Illness identity
Prazo: Pre-intervention (Week 0) and post-intervention (Week 8)
Assessed using the Illness Identity Questionnaire, which evaluates how individuals integrate a chronic illness into their sense of self. Scores reflect different illness identity orientations, with higher scores indicating stronger endorsement of the corresponding identity state. Scale title: Illness Identity Questionnaire (IIQ) Minimum value: 1 (Strongly Disagree) Maximum value: 5 (Strongly Agree) Interpretation: Subscale scores reflect distinct illness identity states; higher scores indicate greater endorsement of that identity orientation
Pre-intervention (Week 0) and post-intervention (Week 8)
Social connectedness
Prazo: Pre-intervention (Week 0) and post-intervention (Week 8)
Measured using the Social Connectedness Scale (SCS), which assesses perceived closeness to others and sense of belonging. Scale title: Social Connectedness Scale (SCS) Minimum value: 1 (Strongly Disagree) Maximum value: 6 (Strongly Agree) Interpretation: Higher scores indicate greater feelings of social connectedness and belonging.
Pre-intervention (Week 0) and post-intervention (Week 8)
Self-reported well-being
Prazo: Pre-intervention (Week 0) and post-intervention (Week 8)
Measured using the WHO-5 is a self-report instrument measuring mental well-being. Scale title: Psychosocial functioning scale (PFQ) Minimum value: 0 (At no time) Maximum value: 5 (All of the time) Interpretation: Higher scores indicate greater well-being.
Pre-intervention (Week 0) and post-intervention (Week 8)
Self-esteem
Prazo: Pre-intervention (Week 0) and post-intervention (Week 8)
Measured using the Rosenberg Self-Esteem Scale (RSE), which assesses global self-worth, self-worth and self-acceptance. Scale Minimum value: 1 (Strongly agree) Maximum value: 4 (Strongly disagree) Interpretation: Higher total scores indicating more positive self-esteem.
Pre-intervention (Week 0) and post-intervention (Week 8)
Qualitative themes from interviews and group reflections
Prazo: Pre-intervention (Week 0) and post-intervention (Week 8)
Semi-structured interviews will explore participant experiences of identity development, meaning-making, peer support, and emotional processing. Transcripts will be analyzed using thematic analysis to identify recurring patterns and narrative themes related to chronic illness experience and psychosocial adaptation.
Pre-intervention (Week 0) and post-intervention (Week 8)

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

University of California, San Francisco

Investigadores

  • Investigador principal: Anoushka Sinha, MD, MS, University of California, San Francisco
  • Cadeira de estudo: Lina Lew, BS, University of California, San Francisco
  • Cadeira de estudo: Calis Lim, BS, Rosalind Franklin University

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

13 de julho de 2026

Conclusão Primária (Estimado)

1 de setembro de 2026

Conclusão do estudo (Estimado)

1 de setembro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

29 de maio de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

29 de maio de 2026

Primeira postagem (Real)

4 de junho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

11 de agosto de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

7 de agosto de 2026

Última verificação

1 de agosto de 2026

Mais Informações

Termos relacionados a este estudo

Termos MeSH relevantes adicionais

Outros números de identificação do estudo

  • 26-46489

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever